Podcast

Podcast: This Week in Managed Care—Nobel Prize for Immunotherapy and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included the Nobel Prize in Medicine was awarded to 2 people for research into immunotherapy; physician-run accountable care organizations bring savings for Medicare; research highlights the health impacts of sexual harassment and assault.

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Listen above or through one of these podcast services:

Nobel Prize Recognizes Discoveries With T Cells in Immunotherapy

The Long Road: Nobel Prize Winner James Allison Highlights the Value of Research

Physician ACOs Associated With Growing MSSP Savings Over 3 Years

What We're Reading: Demand for Antibiotics; FDA Inspects Juul; Fast Food Consumption

Sexual Assault, Harassment Raise Women's Risk for Physical and Mental Health Issues

Evidence-Based Diabetes Management—September 2018

Read more about the stories in this podcast:

Related Videos
Mike Fazio, Navista, Cardinal Health
Casey Koch, PharmD, sitting for a video interview
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Dr Johnie Rose
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Related Content
The Senate | Image credit: MoiraM - stock.adobe.com
April 29th 2025

Trump’s First 100 Days: Workforce Cuts, Drug Pricing, and Medicaid Reform

Pearl Steinzor
Early actions by the new administration signal major changes in health policy, taxes, and pharmaceutical pricing.
managed care cast logo
April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD
On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
glp-1 Wegovy, semaglutide | Image credit: Patrick Bay Damsted - stock.adobe.com
April 25th 2025

Can Medicare Sustain Widespread Access to GLP-1 Therapies?

Skylar Jeremias
Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.
Managed Care Cast Thumbnail
April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD
Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Money, stethoscope, and calculator on health claims form | Image Credit: © Nadzeya - stock.adobe.com
April 23rd 2025

ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz

Christina Mattina
Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Richard Hughes IV, JD, MPH
April 21st 2025

What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV

Julia Bonavitacola Richard Hughes IV, JD, MPH
Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo